<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00106015</url>
  </required_header>
  <id_info>
    <org_study_id>1288</org_study_id>
    <secondary_id>R01HL079571</secondary_id>
    <nct_id>NCT00106015</nct_id>
  </id_info>
  <brief_title>Diamond Blackfan Anemia Registry (DBAR)</brief_title>
  <acronym>DBAR</acronym>
  <official_title>Diamond Blackfan Anemia Registry (DBAR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwell Health</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to maintain a comprehensive registry of patients with the rare
      inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Diamond Blackfan anemia (DBA) is a heterogeneous genetic disorder characterized by pure red
      cell aplasia, congenital anomalies, a predisposition to pancytopenia and myelodysplasia as
      well as hematopoietic and non-hematopoietic cancer. Anemia usually presents in infancy or
      early childhood and greater than 40% of patients have at least one congenital anomaly. The
      actuarial cancer risk is, as of yet, undetermined. One DBA gene has been cloned and the
      existence of at least two other DBA genes has been inferred by linkage analysis. Penetrance
      and expressivity of DBA genes are highly variable. &quot;Affected&quot; individuals within the same
      family may vary dramatically as to the degree of anemia, response to corticosteroids, the
      presence of congenital anomalies and the development of cancer. Despite improvements in
      understanding of this disorder there are significant deficiencies in knowledge that inhibit
      the exploitation of this syndrome to increase both specific and general knowledge of
      mechanisms of hematopoietic failure, birth defects and cancer predisposition. Furthermore
      this disease will, in the near future, provide a valuable platform to study complex gene
      interactions. There are less than 1000 individuals in the United States and Canada estimated
      to have DBA, representing at least 11 genotypes. Thus, no single center follows sufficient
      numbers of well-characterized patients for meaningful clinical and laboratory investigations.
      Furthermore, clinicians require an accurate knowledge of the clinical and laboratory
      presentation, mode of inheritance, treatment response, outcomes and prognosis to make
      important diagnostic treatment and reproductive decisions. A comprehensive registry that
      captures this information and characterizes patients accurately is therefore essential to
      advance our understanding of DBA, and in the process, knowledge regarding hematopoietic cell
      differentiation, birth defects and cancer predisposition. The registry will be an essential
      component of clinical and laboratory DBA related research and patient care.

      The Diamond Blackfan Anemia Registry (DBAR) was established in 1992, and families were asked
      to participate if a member was affected by the disorder. From this, the Diamond Blackfan
      Anemia Foundation (DBAF) was established, largely as a cooperating entity for families to
      share information. The registry attempts to establish contact with all affected individuals
      at the time of diagnosis, avoiding the pitfalls of reporting bias inherent to the study of
      many diseases for which extraordinary events prompt referral to specialized centers. The
      registry is already capturing a high percentage of the estimated number of new cases per
      year, and has facilitated genetic studies to define the gene(s) responsible for the disorder.
      Thus, the registry has an established track record based on funding from non-NIH sources.

      The study is in response to RFA HL-04-008 on Molecular Mechanisms Underlying Diamond-Blackfan
      Anemia and Other Congenital Bone Marrow Failure Syndromes.

      DESIGN NARRATIVE:

      The objective of this study is to expand and update the DBAR in order to: 1) facilitate
      investigations into the epidemiology and biology of Diamond Blackfan anemia; 2) provide an
      accurate phenotype of DBA patients to facilitate genotype- phenotype correlations; 3) provide
      access of well characterized patients to treatment protocols; 4) provide patients to access
      to research studies; 5) provide patients with results of research studies; 6) serve as a
      resource to patients and their doctors to guide diagnostic, therapeutic, and reproductive
      decisions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2004</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Understanding the epidemiology and biology of Diamond Blackfan anemia</measure>
    <time_frame>yearly</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">850</enrollment>
  <condition>Anemia</condition>
  <condition>Blood Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects diagnosed with Diamond Blackfan anemia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must meet the diagnostic criteria for DBA which include the following:

               1. Normochromic, usually macrocytic and occasionally normocytic anemia developing
                  early in childhood

               2. Reticulocytopenia

               3. Normocellular bone marrow with a selective deficiency of red cell precursors

               4. Normal or slightly decreased leukocyte count

               5. Normal or often increased platelet count
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey M Lipton, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cohen Children's Medical Center of NY /The Feinstein Institutute for Medical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrianna Vlachos, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cohen Children;s Medical Center of NY/ The Feinstein Institute for Medical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eva Atsidaftos, MA</last_name>
    <phone>516-562-1504</phone>
    <email>eatsidaf@northwell.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cohen Children's Medical Center of NY</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Atsidaftos, MA</last_name>
      <phone>518-562-1504</phone>
      <email>eatsidaf@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffey M Lipton, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrianna Vlachos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://dbar.org</url>
  </link>
  <reference>
    <citation>Gazda HT, Grabowska A, Merida-Long LB, Latawiec E, Schneider HE, Lipton JM, Vlachos A, Atsidaftos E, Ball SE, Orfali KA, Niewiadomska E, Da Costa L, Tchernia G, Niemeyer C, Meerpohl JJ, Stahl J, Schratt G, Glader B, Backer K, Wong C, Nathan DG, Beggs AH, Sieff CA. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2006 Dec;79(6):1110-8. Epub 2006 Nov 2.</citation>
    <PMID>17186470</PMID>
  </reference>
  <reference>
    <citation>Gazda HT, Zhong R, Long L, Niewiadomska E, Lipton JM, Ploszynska A, Zaucha JM, Vlachos A, Atsidaftos E, Viskochil DH, Niemeyer CM, Meerpohl JJ, Rokicka-Milewska R, Pospisilova D, Wiktor-Jedrzejczak W, Nathan DG, Beggs AH, Sieff CA. RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol. 2004 Oct;127(1):105-13.</citation>
    <PMID>15384984</PMID>
  </reference>
  <reference>
    <citation>Gazda HT, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Schneider H, Darras N, Hasman C, Sieff CA, Newburger PE, Ball SE, Niewiadomska E, Matysiak M, Zaucha JM, Glader B, Niemeyer C, Meerpohl JJ, Atsidaftos E, Lipton JM, Gleizes PE, Beggs AH. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet. 2008 Dec;83(6):769-80. doi: 10.1016/j.ajhg.2008.11.004.</citation>
    <PMID>19061985</PMID>
  </reference>
  <reference>
    <citation>Landowski M, O'Donohue MF, Buros C, Ghazvinian R, Montel-Lehry N, Vlachos A, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Glader B, Atsidaftos E, Lipton JM, Beggs AH, Gleizes PE, Gazda HT. Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum Genet. 2013 Nov;132(11):1265-74. doi: 10.1007/s00439-013-1326-z. Epub 2013 Jun 30.</citation>
    <PMID>23812780</PMID>
  </reference>
  <results_reference>
    <citation>Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, Leblanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM; Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008 Sep;142(6):859-76. doi: 10.1111/j.1365-2141.2008.07269.x. Epub 2008 Jul 30.</citation>
    <PMID>18671700</PMID>
  </results_reference>
  <results_reference>
    <citation>Lipton JM, Atsidaftos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer. 2006 May 1;46(5):558-64.</citation>
    <PMID>16317735</PMID>
  </results_reference>
  <results_reference>
    <citation>Farrar JE, Nater M, Caywood E, McDevitt MA, Kowalski J, Takemoto CM, Talbot CC Jr, Meltzer P, Esposito D, Beggs AH, Schneider HE, Grabowska A, Ball SE, Niewiadomska E, Sieff CA, Vlachos A, Atsidaftos E, Ellis SR, Lipton JM, Gazda HT, Arceci RJ. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood. 2008 Sep 1;112(5):1582-92. doi: 10.1182/blood-2008-02-140012. Epub 2008 Jun 5.</citation>
    <PMID>18535205</PMID>
  </results_reference>
  <results_reference>
    <citation>Doherty L, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Clinton C, Schneider HE, Sieff CA, Newburger PE, Ball SE, Niewiadomska E, Matysiak M, Glader B, Arceci RJ, Farrar JE, Atsidaftos E, Lipton JM, Gleizes PE, Gazda HT. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2010 Feb 12;86(2):222-8. doi: 10.1016/j.ajhg.2009.12.015. Epub 2010 Jan 28. Erratum in: Am J Hum Genet. 2010 Apr 9;86(4):655.</citation>
    <PMID>20116044</PMID>
  </results_reference>
  <results_reference>
    <citation>Boria I, Garelli E, Gazda HT, Aspesi A, Quarello P, Pavesi E, Ferrante D, Meerpohl JJ, Kartal M, Da Costa L, Proust A, Leblanc T, Simansour M, Dahl N, Fr√∂jmark AS, Pospisilova D, Cmejla R, Beggs AH, Sheen MR, Landowski M, Buros CM, Clinton CM, Dobson LJ, Vlachos A, Atsidaftos E, Lipton JM, Ellis SR, Ramenghi U, Dianzani I. The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat. 2010 Dec;31(12):1269-79. doi: 10.1002/humu.21383.</citation>
    <PMID>20960466</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlachos A, Dahl N, Dianzani I, Lipton JM. Clinical utility gene card for: Diamond Blackfan anemia. Eur J Hum Genet. 2011 May;19(5). doi: 10.1038/ejhg.2010.247. Epub 2011 Jan 19.</citation>
    <PMID>21248735</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlachos A, Muir E. How I treat Diamond-Blackfan anemia. Blood. 2010 Nov 11;116(19):3715-23. doi: 10.1182/blood-2010-02-251090. Epub 2010 Jul 22. Review.</citation>
    <PMID>20651069</PMID>
  </results_reference>
  <results_reference>
    <citation>Farrar JE, Vlachos A, Atsidaftos E, Carlson-Donohoe H, Markello TC, Arceci RJ, Ellis SR, Lipton JM, Bodine DM. Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood. 2011 Dec 22;118(26):6943-51. doi: 10.1182/blood-2011-08-375170. Epub 2011 Nov 1.</citation>
    <PMID>22045982</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood. 2012 Apr 19;119(16):3815-9. doi: 10.1182/blood-2011-08-375972. Epub 2012 Feb 23.</citation>
    <PMID>22362038</PMID>
  </results_reference>
  <results_reference>
    <citation>Gazda HT, Preti M, Sheen MR, O'Donohue MF, Vlachos A, Davies SM, Kattamis A, Doherty L, Landowski M, Buros C, Ghazvinian R, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Glader B, Atsidaftos E, Lipton JM, Gleizes PE, Beggs AH. Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum Mutat. 2012 Jul;33(7):1037-44. doi: 10.1002/humu.22081. Epub 2012 Apr 16.</citation>
    <PMID>22431104</PMID>
  </results_reference>
  <results_reference>
    <citation>Markello TC, Carlson-Donohoe H, Sincan M, Adams D, Bodine DM, Farrar JE, Vlachos A, Lipton JM, Auerbach AD, Ostrander EA, Chandrasekharappa SC, Boerkoel CF, Gahl WA. Sensitive quantification of mosaicism using high density SNP arrays and the cumulative distribution function. Mol Genet Metab. 2012 Apr;105(4):665-71. doi: 10.1016/j.ymgme.2011.12.015. Epub 2011 Dec 24.</citation>
    <PMID>22277120</PMID>
  </results_reference>
  <results_reference>
    <citation>Vlachos A, Farrar JE, Atsidaftos E, Muir E, Narla A, Markello TC, Singh SA, Landowski M, Gazda HT, Blanc L, Liu JM, Ellis SR, Arceci RJ, Ebert BL, Bodine DM, Lipton JM. Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome. Blood. 2013 Oct 3;122(14):2487-90. doi: 10.1182/blood-2013-06-509935. Epub 2013 Aug 13.</citation>
    <PMID>23943650</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2005</study_first_submitted>
  <study_first_submitted_qc>March 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2005</study_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwell Health</investigator_affiliation>
    <investigator_full_name>Jeffrey Lipton</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>inherited pure red cell aplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Diamond-Blackfan</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

